Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
In November 2023, CDC published new recommendations for hepatitis C testing for perinatally exposed infants and children.News Article updated on 12/19/2023
-
Update on Mpox Vaccination Rates
JYNNEOS vaccine coverage remains highly variable across jurisdictions with low uptake of the second dosage, as of November 2023 data.News Article updated on 01/08/2024 -
Best Practices Highlight: New York City Medical Home Model
A New York City HIV medical home model has documented significant improvements in care re-engagement and viral suppression.Blog updated 08/23/2023
-
Clinical Trial: New Gonorrhea Treatment Effective
A single dose of a novel oral antibiotic called zoliflodacin has been found to be as safe and effective as standard therapy for uncomplicated urogenital gonorrhea in an international Phase 3 non-inferiority clinical trial.News Article updated on 11/16/2023 -
Over 50,000 Health Professionals Trained: AETC 2022 Report
In 2021-2022, 56,383 health professionals received training in HIV clinical topics, provided by the HIV clinical training network under HRSA's Ryan White HIV/AIDS Program.News Article updated on 05/06/2024 -
Mpox Treatment Study Underway: How to Take Part
Insights on how to take part in the clinical trial are outlined in HIV.gov's Help Scientists Find a Safe and Effective Mpox Treatment.News Article updated on 05/17/2024 -
HAB Updates its Mpox Info
HRSA's HIV/AIDS Bureau has updated its mpox resources.News Article updated on 05/23/2024 -
2024 National HIV Testing Day Theme Announcement
The National HIV Testing Day theme for 2024 is “Level up your self-love: check your status.”News Article updated on 05/28/2024 -
HIV Prevention and Care Improvements Summarized in CDC Surveillance Reports
In the U.S., the number of new HIV cases continue to decline, most people are linked to care within one month of their HIV diagnosis, and 69% reach viral suppression within 6 months of HIV diagnosis.News Article updated on 06/10/2024 -
Doxy PEP Guidelines Issued by CDC
CDC has issued the first-ever guidelines recommending use of doxy PEP (doxycycline postexposure prophylaxis) for the prevention of STIs among select populations.News Article updated on 06/06/2024 -
Opioid Use Among Incarcerated Persons and Impact of Medications
A wealth of data on the impact of substance abuse among incarcerated persons and how medications can make a positive impact are summarized in Quick Take, Medications for Opioid Use Disorder in U.S. Jails and Prisons: Status Update.News Article updated on 04/02/2024 -
Hepatitis Rates Improve Across the Board: CDC Surveillance Report
Rates of hepatitis, across the ABC alphabet, have declined in recent years, according to the 2022 Viral Hepatitis Surveillance Report (CDC, April 2024).News Article updated on 04/09/2024 -
Ryan White HIV Care and Black/African American People
A significant proportion of African Americans living with HIV/AIDS get care from HRSA's Ryan White HIV/AIDS Program.
Blog updated 03/29/2024
-
Ryan White HIV Care and Women and Girls
From 2010 through 2022, viral suppression increased from 66.3% to 89.9% among female RWHAP clients receiving HIV medical care.Blog updated 04/17/2024
-
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
Ryan White and Hepatitis/HIV Care
Access these tools on integrating hepatitis screening and treatment within HIV care programs.
Blog updated 05/29/2024
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from the 2017 Ryan White Clinical Conference by Dr. Laura Cheever.
Blog updated 01/13/2023
-
Evidence-Informed Interventions in Four HIV Care Continuum Manuals
Evidence-informed interventions for engaging persons with HIV in care (incarceration/community release; buprenorphine; patient navigation for women of color; peer linkages for women of color).
Blog updated 01/07/2021
-
New Tools and Webinars from the AETC Clinical Training Network
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024